[Efficacy of cereton in the acute period of ischemic stroke].
A study included 40 patients with ischemic stroke who were admitted to the hospital not later than 24 h after disease manifestation. All patients received basic therapy. A main group (20 patients) received cereton (choline alfoscerate) as an add-on drug in dosage 1000mg/day intravenous in drops. A comparison analysis was carried out on days 1 and 21 using the following scales: NIHSS, Barthel, Rankin, MMSE, clock drawing test. The rapid regress of neurological deficit (p<0,05), better rehabilitation of cognitive functions (p<0,05) and functional status were found to the 21st day in the main group compared to the control one. No side-effects were observed in patients treated with cereton.
M F
MF
Ismagilov
O V
OV
Vasilevskaia
R T
RT
Gaĭfutdinov
T M
TM
Strakhova
I A
IA
Kuz'mina
D000208:Acute Disease; D000368:Aged; D003071:Cognition / Q000502:physiology; D004305:Dose-Response Relationship, Drug; D005260:Female; D005500:Follow-Up Studies; D005997:Glycerylphosphorylcholine / Q000008:administration & dosage*; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D020521:Stroke / Q000188:drug therapy* / Q000503:physiopathology; D016896:Treatment Outcome
D005997:Glycerylphosphorylcholine